EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Programming the tumor microenvironment through microbiome-driven mechanisms

Jhommara Bautista, Sebastián Calderón-Cevallos, Ana María Salvador-Baquero, Xavier Naranjo-Castillo, Andrés López-Cortés

Frontiers in Cellular and Infection Microbiology · 09.06.2026 · 16

DOI: 10.3389/fcimb.2026.1857151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 09.06.2026. Verfasst von Jhommara Bautista und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador. Hauptthemen laut MEDLINE: Tumor Microenvironment, Microbiota, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) comprises interacting immune, stromal, and metabolic compartments that determine tumor behavior and treatment response. Microbial communities modulate host signaling within the TME through metabolite-driven and receptor-mediated mechanisms. Lipopolysaccharides (LPS), short-chain fatty acids (SCFAs), bile acids, and amino acid–derived metabolites engage host receptors, including Toll-like receptors, G protein–coupled receptors, and aryl hydrocarbon receptor pathways, to regulate immune cell differentiation, antigen presentation, and metabolic adaptation. These microbiome-derived signals promote context-dependent immune suppression or immune activation according to metabolite concentration, receptor engagement, and immune cell composition, thereby influencing tumor progression and immune evasion. Host-driven inflammation and metabolic constraints reshape microbial composition and function within tumor-associated niches. Microbiome-associated mechanisms contribute to tumor initiation, progression, and therapeutic response through modulation of immune checkpoint activity and drug metabolism. Major limitations include reliance on associative human data, methodological variability across sequencing approaches, contamination in low-biomass samples, and incomplete integration of multi-omics datasets. Clinical translation requires mechanistic validation, longitudinal study designs, and standardized analytical frameworks to define reproducible microbiome-associated signatures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentMicrobiotaNeoplasmsHumansAnimalsSignal TransductionToll-Like ReceptorsMultiomicsFatty Acids, VolatileLipopolysaccharides

Stichwörter der Autor:innen

clinical translationdrug metabolismimmune checkpoint activitymetabolitesmicrobiome-derived signalstumor microenvironment

Substanzen

Toll-Like ReceptorsFatty Acids, VolatileLipopolysaccharides

Autor:innen und Institutionen

  • Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.

Zitieren

APA

Bautista, J., Calderón-Cevallos, S., Salvador-Baquero, A. M., Naranjo-Castillo, X., & López-Cortés, A. (2026). Programming the tumor microenvironment through microbiome-driven mechanisms. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1857151

Vancouver

Bautista J, Calderón-Cevallos S, Salvador-Baquero AM, Naranjo-Castillo X, López-Cortés A. Programming the tumor microenvironment through microbiome-driven mechanisms. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1857151

BibTeX
@article{Bautista2026,
  author = {Bautista, Jhommara and Calderón-Cevallos, Sebastián and Salvador-Baquero, Ana María and Naranjo-Castillo, Xavier and López-Cortés, Andrés},
  title = {Programming the tumor microenvironment through microbiome-driven mechanisms},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1857151}
}
Kostenlos starten →